The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Tue, 04.03.2025
Wolters Kluwer
NL0000395903
Wolters Kluwer Health is integrating its UpToDate solution with the healthcare agent service in Microsoft Copilot Studio. This integration aims to explore and validate the use of GenAI to provide clinicians with relevant and patient-specific evidence-based content from UpToDate® at the point of care. The Microsoft healthcare agent service is desig...
Wolters Kluwer has introduced powerful new functionality that allows businesses to electronically file Form 5330 with the Internal Revenue Service (IRS) directly from employee benefit and pension software ftwilliam.com. Users are now able to efficiently prepare, submit, and track their Form 5330 filings through a familiar and easy-to-use interface...
Wolters Kluwer Health and Suki® are partnering to streamline administrative tasks for clinicians by making UpToDate®, a market-leading clinical decision support (CDS) solution, accessible from within Suki Assistant.
Suki is a leader in healthcare AI that aims to make healthcare technology invisible and assistive so clinicians can focus on what’s...
Wolters Kluwer, a global leader in professional information, software solutions and services, today announces Jim Pelletier, CIA, CGAP, Lead Product Manager for Wolters Kluwer TeamMate, will present an expert panel at the upcoming 2025 IIA Great Audit Minds (GAM) conference on March 11, 2025.
Pelletier will lead a panel discussion focused on “Th...
Wolters Kluwer has published the February 2025 edition of its Blue Chip Economic Indicators survey, which finds only 10% of the panel’s 47 leading economists anticipating a rate cut at the Fed’s March meeting. Additionally, a majority of panelists (80%) believe that the expected increase in tariffs will provide a significant boost to U.S. inflatio...
Wolters Kluwer’s ELM Solutions business has been recognized as Business-to-Business Company of the Year by the 14th annual Best in Biz Awards. The program’s independent panel of prestigious business journalists also celebrated ELM Solutions’ innovative AI solutions and powerful approach to engaging customers.
“ELM Solutions is a trusted partner ...
Wolters Kluwer, a global leader in professional information, software solutions, and services, today announced that its CCH® Tagetik expert solution has been recognized as a Leader, for the fifth consecutive year, in the Nucleus Research CPM Technology Value Matrix.
In its new report, Nucleus commends the comprehensive portfolio offered through ...
Wolters Kluwer, a global leader in professional information, software solutions and services, today announced the launch of a new report Paving the Way to Integrated Assurance: A Proactive Approach.” This report outlines the critical role integrated assurance plays in risk management and organizational success in today's complex business environme...
Wolters Kluwer Health today announced that KLAS Research has recognized the Sentri7® clinical surveillance solution as Best in KLAS® for infection control and monitoring in the 2025 Best in KLAS – Software and Services report. KLAS Research, which specializes in monitoring and reporting the performance of healthcare solution providers, rated Sentr...
Wolters Kluwer Health has two UpToDate® solutions ranked #1 in the 2025 Best in KLAS – Software and Services report released today. KLAS Research, which specializes in monitoring and reporting the performance of healthcare vendors, rated UpToDate Patient-Driven Care Management and Patient Education as top performing solutions that enable patients ...
You have pressed the "". We would like to inform you that you are now leaving the information service of the portal site ayondo.com. You will be redirected to . After confirming the "Continue" button, you confirm that you have been informed of this. You also confirm that you are carrying out this process of your own free will and that it is not the result of any promotional activity or other influence. Continue to .